We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BCDA market cap is 10.09M. The company's latest EPS is USD -2.5241 and P/E is -0.87.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 357k | 13k | 55k | 3k | 0 |
| Operating Income | -2.6M | -2.08M | -2.28M | -1.65M | -1.76M |
| Net Income | -2.57M | -2.07M | -2.27M | -1.65M | -1.74M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 710k | 145k | 1.02M | 1.35M | 477k |
| Operating Income | -14.21M | -15.53M | -12.63M | -11.9M | -11.64M |
| Net Income | -14.71M | -15M | -12.62M | -11.91M | -11.57M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.75M | 2.99M | 2.68M | 2.89M | 6.27M |
| Total Liabilities | 4.41M | 4.59M | 4.95M | 4.85M | 3.51M |
| Total Equity | -660k | -1.6M | -2.28M | -1.96M | 2.75M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.68M | 23.42M | 15.72M | 9.79M | 2.99M |
| Total Liabilities | 5.31M | 4.25M | 5.34M | 4.9M | 4.59M |
| Total Equity | 2.37M | 19.18M | 10.38M | 4.89M | -1.6M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.12M | -9.97M | -1.53M | -2.84M | -5.45M |
| Investing | -12k | -12k | N/A | -3k | -5k |
| Financing | 2.61M | 3.73M | 1.38M | 3.16M | 9.29M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.45M | -12.36M | -10.37M | -10.56M | -9.97M |
| Investing | -146k | -32k | -116k | -70k | -12k |
| Financing | 9.82M | 28.21M | 1.95M | 5.12M | 3.73M |
| Market Cap | 10.09M |
| Price to Earnings Ratio | -0.87 |
| Price to Sales Ratio | 21.13 |
| Price to Cash Ratio | 9.14 |
| Price to Book Ratio | -6.29 |
| Dividend Yield | - |
| Shares Outstanding | 4.58M |
| Average Volume (1 week) | 84.51k |
| Average Volume (1 Month) | 48.46k |
| 52 Week Change | -67.91% |
| 52 Week High | 8.85 |
| 52 Week Low | 1.625 |
| Spread (Intraday) | 0.18 (7.86%) |
| Company Name | BioCardia Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.biocardia.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
